Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


23.07.2018

1 Am J Gastroenterol
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
2 Hepatology
1 J Gastroenterol
1 J Hepatol
2 J Med Virol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. YOUNOSSI ZM
    Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status.
    Am J Gastroenterol. 2018 Jul 18. pii: 10.1038/s41395-018-0200.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. STEWART RA, MacDonald BR, Chu TC, Moore JD, et al
    Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
    Dig Dis Sci. 2018 Jul 16. pii: 10.1007/s10620-018-5205.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. ELHELBAWY M, Abdel-Razek W, Alsebaey A, Hashim M, et al
    Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment.
    Eur J Gastroenterol Hepatol. 2018 Jul 18. doi: 10.1097/MEG.0000000000001215.
    PubMed     Text format     Abstract available


    Gastroenterology

  4. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Text format     Abstract available


    Hepatology

  5. TUCCI F, Calbi V, Barzaghi F, Migliavacca M, et al
    Successful treatment with Harvoni((R)) in an ADA-SCID infant with HCV infection allowed gene therapy with Strimvelis((R)).
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30160.
    PubMed     Text format     Abstract available

  6. JAIN MK, Thamer M, Therapondos G, Shiffman ML, et al
    Has Access to HCV Therapy Changed for Patients with Mental Health or Substance Use Disorders in the DAA Period?
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30171.
    PubMed     Text format     Abstract available


    J Gastroenterol

  7. SUDA G, Kurosaki M, Itakura J, Izumi N, et al
    Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.
    J Gastroenterol. 2018 Jul 17. pii: 10.1007/s00535-018-1495.
    PubMed     Text format     Abstract available


    J Hepatol

  8. VERMEHREN J, Park JS, Jacobson I, Zeuzem S, et al
    Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection.
    J Hepatol. 2018 Jul 10. pii: S0168-8278(18)32181.
    PubMed     Text format     Abstract available


    J Med Virol

  9. MORIO K, Imamura M, Kawakami Y, Nakamura Y, et al
    Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.
    J Med Virol. 2018 Jul 17. doi: 10.1002/jmv.25267.
    PubMed     Text format     Abstract available

  10. HASHEM M, Zaghla H, Zakaria Z, Allam WR, et al
    High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.
    J Med Virol. 2018 Jul 16. doi: 10.1002/jmv.25270.
    PubMed     Text format     Abstract available


    PLoS One

  11. TIEU HV, Laeyendecker O, Nandi V, Rose R, et al
    Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
    PLoS One. 2018;13:e0200269.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: